Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe three licensed injection sites for weight loss medicines such as Mounjaro and Wegovy are the abdomen, the front of the thigh, and the outer upper arm. Rotating between them each week is one of the simplest things you can do to keep injections comfortable and effective. These are prescription-only medicines; a GPhC-registered prescriber assesses whether they are clinically appropriate for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When clinicians talk about weight loss injection sites, they mean three specific areas of the body identified in the Summary of Product Characteristics (SmPC) for both tirzepatide (Mounjaro) and semaglutide (Wegovy): the abdomen, the front of the thigh, and the outer upper arm. Each of these areas carries enough subcutaneous fat to allow the medicine to absorb steadily into the bloodstream, which is what makes them suitable.
The abdomen is where most people start. It is easy to see, easy to pinch, and you can inject anywhere roughly five centimetres from the navel. The front of the thigh (the middle third, not the inner or outer edge) is a solid second option, and the outer upper arm works well if someone else is giving the injection or you are confident with your own technique. Wherever you choose, the NHS guidance on weight-management injections covers the practical basics clearly, and your Patient Information Leaflet is always the definitive reference for your specific medicine.
One thing worth noting: you can also compare how the three GLP-1 injection sites differ in comfort and convenience — something our prescribers get asked about regularly. There is no single best answer, and personal preference matters.
This is the step that catches people out. It is tempting to find a spot that does not hurt and stay with it. The problem is that repeated injections into the same small area damage the underlying fatty tissue over time, causing a condition called lipohypertrophy, a firm, lumpy patch that looks slightly raised or feels different to the surrounding skin. Medicine injected into that tissue absorbs erratically, which can affect how well treatment works.
Rotation solves this. The principle is straightforward: move the injection point at least a few centimetres from the previous one each week, and cycle between the three sites over time. Some people find it helpful to think in a simple pattern (left thigh one week, right thigh the next, abdomen the week after) but the exact scheme is less important than the habit of not going back to the same spot twice in a row.
If you notice any lump, bruising, redness, or persistent soreness at a site, let your aftercare team know. You can also read more about finding the most comfortable injection site for your own anatomy and lifestyle. That kind of practical question is exactly what aftercare is for.
Technique matters as much as location. Before you inject, wash your hands. If you are using the outer upper arm you may need a mirror or a carer's help; using the abdomen or thigh is easier to manage independently. Pinch a fold of skin gently, hold the pen at the angle described in the leaflet, press the button and hold it in place for the count the leaflet specifies. Then release the skin fold before removing the pen.
Many people feel anxious before their first injection. That is entirely normal. The pen devices used for Mounjaro and Wegovy are designed to make the process as straightforward as possible, and the physical sensation is typically much milder than people expect. If needles genuinely concern you, mentioning it during your consultation means the prescriber can talk through technique and address any questions before your treatment starts.
Changing needles before each injection is standard practice; replacement needles are available if you need them. Used needles should go into a sharps container rather than general waste; a one-litre sharps bin is a practical way to stay safe and compliant at home.
Most people settle into a comfortable routine within a few weeks. If you are experiencing consistent pain, visible skin changes at injection sites, or you are unsure whether you are injecting correctly, that is a conversation for your prescriber, not a forum. Do not adjust your injection depth, angle or site without clinical input.
There is also a broader question about which site suits you at different points in treatment, for instance, whether preferences shift as you move through the dose titration schedule. Our clinical team answers these kinds of questions as part of ongoing aftercare. You can read more about how weight loss injections work in practice, or explore which injection site tends to work best for different people. If you are thinking about treatment more broadly, the treatment overview page is a good place to start. The FAQs page covers many common practical questions about starting treatment, and the cost of weight loss injections is explained in plain terms there too, so you can go into any consultation clear on what to expect. For those who want to understand the wider landscape of options, including how weight loss HGH injections compare to GLP-1 treatments, the weight loss treatments overview covers what is currently licensed in the UK.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.